Find Therapeutics Inc., a US-based biopharmaceutical company, announced on Monday that it has named Paul F Truex as its new director effective 1 August 2022.

Presently, Truex is the chairman and CEO of Thryv Therapeutics (formerly LQT Therapeutics, Laval, Quebec). He has three decades of experience in the pharmaceutical industry, including having founded and headed several successful biotech companies while serving on multiple boards. He has participated in various IPOs including Milestone (board member), Trius (board member), Anthera (CEO), Peninsula (CEO), and Versicor (VP).

Philippe Douville, Find Therapeutics chief executive officer, said, 'On behalf of the board of directors, it is a pleasure to welcome Paul to our team. Paul's long history of successful leadership, coupled with his extensive network in the life sciences ecosystem makes him an ideal person for this role. I look forward to working closely with Paul as we continue to advance our programs.'